Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells
- 1 June 2001
- journal article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 4 (2), 81-91
- https://doi.org/10.1038/sj.pcan.4500506
Abstract
Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate.Keywords
This publication has 34 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Molecular biology of prostate carcinogenesisCritical Reviews in Oncology/Hematology, 1999
- Growth Inhibition of Chronic Myelogenous Leukemia Cells by ODN-1, an Aptameric Inhibitor of p210bcr-ablTyrosine Kinase ActivityAntisense and Nucleic Acid Drug Development, 1998
- Genistein-Induced Apoptosis of Prostate Cancer Cells is Preceded by a Specific Decrease in Focal Adhesion Kinase ActivityPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1997
- Inhibition of Protein-Tyrosine Kinase Activity in Intact Cells by the Aptameric Action of OligodeoxynucleotidesAntisense Research and Development, 1995
- Aptameric inhibition of p210bcr-abltyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structureNucleic Acids Research, 1994
- The multistep nature of cancerTrends in Genetics, 1993
- Electroporation enhances c-myc antisense oligodeoxynucleotide efficacyNucleic Acids Research, 1993
- Molecular themes in oncogenesisCell, 1991
- Clinical Evidence for and Implications of the Multistep Development of Prostate CancerJournal of Urology, 1990